CClinicalTrials.gg
CompletedNCT07674602Updated Jun 29, 2026

Effects of Fried Foods Prepared in Palm Oil Blended With Canola Oil Containing Surfactants and Green Tea Extract

An interventional study of Fried Foods Prepared in Palm Oil Blended With Canola Oil Containing Surfactants and Green Tea Extract and Fried Foods Prepared in Palm Oil in Healthy Adult Participants, sponsored by Chulalongkorn University. Completed at 1 site in Thailand. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-29.

Sponsored by Chulalongkorn University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 7 months after the study started (first participant enrolled Nov 2025, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The objectives of the study were to investigate effects of foods prepared in palm oil blended with canola oil containing surfactants and green tea extract on postprandial triglyceride levels in healthy volunteers. There were 22 subjects in the study. They were divided into 2 groups: 1.comsumed foods fried in palm oil blended with canola oil containing surfactants and green tea extract and 2.comsumed foods fried in palm oil. Postprandial triglyceride, lipid profiles, and liver and kidney functions were evaluated before and after taking 5 hours.

02

Conditions studied

  • Healthy Adult Participants

Keywords

  • Healthy
  • canola
  • surfactant
  • green tea
03

In context

Lead sponsor

Chulalongkorn University is the lead sponsor of 312 studies on the registry; 59 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male or female participants aged 18-60 years.
  • Participants with fasting triglyceride levels \<150 mg/dL (after fasting for at least 8-12 hours before blood collection).
  • Participants without a history of cardiovascular disease, diabetes mellitus, thyroid disease, cancer, liver disease, or kidney disease.
  • Participants who are able to read and write.
  • Participants who voluntarily agree to participate after receiving information regarding the study objectives, procedures, potential risks, and expected benefits; are able to comply with the study protocol; and provide written informed consent.

Exclusion criteria

Exclusion Criteria:

  • Participants with a history of allergy or adverse reactions, such as skin, respiratory, or gastrointestinal symptoms, after consuming foods containing canola oil, polyglycerol esters of fatty acids (PGEs), green tea extract, palm oil, or banana.
  • Participants who have consumed medications, dietary supplements, herbal products, or foods that may affect metabolism, such as weight-loss products or L-carnitine, within 2 weeks prior to enrollment.
  • Participants who regularly use medications that may affect lipid metabolism or blood lipid levels, such as corticosteroids or lipid-lowering agents.
  • Participants with serious underlying diseases or poorly controlled medical conditions, such as cancer, cardiovascular disease, or immunodeficiency disorders.
  • Participants with impaired liver or kidney function, defined as AST/ALT levels >3 times the upper limit of normal or kidney disease with an estimated glomerular filtration rate (eGFR) \<60 mL/min/1.73 m².
  • Female participants who are pregnant or breastfeeding.
  • Participants who regularly smoke.
  • Participants who regularly consume alcohol.
  • Participants who are currently participating in another research study.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Fried Foods Prepared in Palm Oil Blended With Canola Oil Containing Surfactants and Green Tea Extrac

    Take fried foods prepared in palm oil blended with canola oil containing surfactants and green tea extract 7 pieces.

    Other: Fried Foods Prepared in Palm Oil Blended With Canola Oil Containing Surfactants and Green Tea Extract

  • Active comparator
    Control group

    Take fried foods prepared in palm oil 7 pieces

    Other: Fried Foods Prepared in Palm Oil

Interventions

  • OtherFried Foods Prepared in Palm Oil Blended With Canola Oil Containing Surfactants and Green Tea Extract

    Take fried foods prepared in palm oil blended with canola oil containing surfactants and green tea extract 7 pieces.

  • OtherFried Foods Prepared in Palm Oil

    Take fried foods prepared in palm oil 7 pieces.

06

What researchers measure

Primary outcomes

  1. Postprandial triglyceride

    Postprandial triglyceride in blood

    Time frame: 5 hours

Secondary outcomes

  1. Total cholesterol in blood

    Time frame: 5 hours

  2. High Density Lipoprotein in blood

    Time frame: 5 hours

  3. Low Density Lipoprotein in blood

    Time frame: 5 hours

  4. Fasting blood glucose

    Time frame: 5 hours

  5. Creatinine in blood

    Time frame: 5 hours

  6. Blood Urea Nitrogen

    Time frame: 5 hours

  7. Aspartate Aminotransferase in blood

    Time frame: 5 hours

  8. Alanine Aminotransferase in blood

    Time frame: 5 hours

  9. Alkaline Phosphatase in blood

    Time frame: 5 hours

  10. Plasma antioxidant

    Time frame: 5 hours

07

Study locations

1 site
  • Chulalongkorn University
    Bangkok, 10330, Thailand
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07674602
Lead sponsor
Chulalongkorn University
Responsible party
Pornanong Aramwit, Pharm.D., Ph.D (Professor, Chulalongkorn University) — Principal investigator
First posted
Jun 29, 2026
Start date
Nov 1, 2025
Primary completion
Mar 31, 2026
Completion
Apr 15, 2026
Last update
Jun 29, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion